Research Papers:

This article has been corrected. Correction in: Oncotarget. 2020; 11:212-212.

UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells

Chloe M. Falvey, Tracey R. O’Donovan, Shereen El-Mashed, Michelle J. Nyhan, Seamus O’Reilly and Sharon L. McKenna _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:23479-23491. https://doi.org/10.18632/oncotarget.15182

Metrics: PDF 2790 views  |   HTML 2988 views  |   ?  


Chloe M. Falvey1, Tracey R. O’Donovan1, Shereen El-Mashed1, Michelle J. Nyhan1, Seamus O’Reilly2, Sharon L. McKenna1

1Cork Cancer Research Centre, University College Cork, Cork, Ireland

2Department of Oncology, Cork University Hospital, Cork, Ireland

Correspondence to:

Sharon L. McKenna, email: [email protected]

Keywords: esophageal, autophagy, apoptosis, ISG15, UBE2L6

Received: February 05, 2016     Accepted: January 16, 2017     Published: February 08, 2017


Esophageal cancer remains a poor prognosis cancer due to advanced stage of presentation and drug resistant disease. To understand the molecular mechanisms influencing response to chemotherapy, we examined genes that are differentially expressed between drug sensitive, apoptosis competent esophageal cancer cells (OE21, OE33, FLO-1) and those which are more resistant and do not exhibit apoptosis (KYSE450 and OE19). Members of the ISG15 (ubiquitin-like) protein modification pathway, including UBE2L6 and ISG15, were found to be more highly expressed in the drug sensitive cell lines. In this study, we evaluated the contribution of these proteins to the response of drug sensitive cells. Depletion of UBE2L6 or ISG15 with siRNA did not influence caspase-3 activation or nuclear fragmentation following treatment with 5-fluorouracil (5-FU). We assessed autophagy by analysis of LC3II expression and Cyto-ID staining. Depletion of either ISG15 or UBE2L6 resulted in enhanced endogenous autophagic flux. An increase in autophagic flux was also observed following treatment with cytotoxic drugs (5-FU, rapamycin). In ISG15 depleted cells, this increase in autophagy was associated with improved recovery of drug treated cells. In contrast, UBE2L6 depleted cells, did not show enhanced recovery. UBE2L6 may therefore influence additional targets that limit the pro-survival effect of ISG15 depletion. These data identify UBE2L6 and ISG15 as novel inhibitors of autophagy, with the potential to influence chemosensitivity in esophageal cancer cells.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15182